LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
35 hedge funds and large institutions have $16.4M invested in Landos Biopharma, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 17 closing their positions.
Holders
35
Holders Change
-10
Holders Change %
-22.22%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
7
Reduced
14
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$283K |
| 2 |
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$30K |
| 3 |
E
3
Ergoteles
New York
|
$17K |
| 4 |
4
Goldman Sachs
New York
|
$31K |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$16K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
51
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
52
Osaic Holdings
Scottsdale,
Arizona
| $0 | 418 | – | – |
|
|
CS
53
Credit Suisse
Zurich,
Switzerland
| $0 | 3 | +3 | New |
|